Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
These medications are not recommended during pregnancy, and they may increase the risk of hypoglycemia (low blood sugar) when used with insulin or sulfonylureas
In the next article, well dig deeper into the mental health effects of GLP-1 medications
Oral Wegovy at the higher 25 mg dose for weight loss was approved by the US FDA in December 2025
But reduced food intake means reduced nutrient intake, and several nutrients are absolutely essential for hair follicle cycling
Record keeping and protocol documentation A calculator gives you the right numbers